Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis — Stella

Recruiting

Back to Transthyretin Amyloidosis trials

Trial locations(53 sites)

United States

Research Site, La Jolla, California

Research Site, Los Angeles, California

Research Site, San Francisco, California

Research Site, San Francisco, California

Research Site, New Haven, Connecticut

Key details

Sponsor

AstraZeneca

Collaborators

ICON plc

Enrollment target

~1,850 participants

Started

June 2024

Primary completion

December 2031

Age range

18 Years – 130 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.